David M. Stack

David M. Stack (chief executive) discloses dealings in 3 companies, chiefly Pacira BioSciences, Inc., Amarin CORP Plc\uk and Chiasma, Inc. In total, 17 filings cover trades dated from 15 January 2016 to 14 June 2023.

In open-market terms, that means 1 purchase worth €19k on one side and 6 sales worth €1.6M on the other. The totals exclude 3 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 6 option exercises. So far in 2023, the count stands at no purchases and 1 sale.

Most recently, on 16 June 2023, the filings show a share grant in Pacira BioSciences, Inc. The last insider purchase was made public on 7 June 2021, 1,959 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.